Keratoconus Treatment CR-3 using Ultra Violet Light and Riboflavin
A new Keratoconus treatment explained.
A revolutionary
treatment for
keratoconus has been developed by eye surgeons using CR-3 ( CORNEAL COLLAGEN CROSS LINKING WITH RIBOFLAVIN )
This method works by increasing collagen (the bulk of the cornea is made of collagen fibres) cross linking which in turn strengthens the cornea and helps reduce the 'bulging out ' that occurs in Keratoconus- consequently improving vision !
The procedure involves application of topical anaesthetic to the front of the eye.Riboflavin (vitaminB2) drops are thenapplied.When these drops have been well absorbed UV light is focussed on the central corneal area for 30 mins to activate the drops.
Riboflavin not only enhances the cross-linking/strenghtening effect of the UV light but also absorbs the UV light such that the inner layers of the cornea and eye structures are protected from damage.
The long term effects of this treatment are unknown.Although clinical research has predicted promising reults.
Cross linking treatments can be combined with Intacs to further help improve and stabilize the vision correction obtained for patients with Keratoconus.